Monitor future 13G filings for any change in BlackRock's position; a shift to 13D would signal activist intent. No immediate catalyst from this routine passive update.
Price Chart
Executive Summary
BlackRock, Inc. filed an amendment to its Schedule 13G for Trevi Therapeutics, Inc., reporting beneficial ownership of 9,779,593 shares of common stock (6.9% of outstanding shares) as of September 30, 2026. This represents a decrease from the prior filing's 9,779,593 shares (6.9%), indicating the stake was unchanged. As a passive institutional investor maintaining a stable position, this filing is routine and carries no directional signal.
Key Financial Metrics
Key Facts
- BlackRock reported beneficial ownership of 9,779,593 shares of Trevi Therapeutics common stock as of September 30, 2026.
- The stake represents 6.9% of outstanding shares, unchanged from the prior filing.
- BlackRock certifies the securities were acquired and are held in the ordinary course of business, not for changing or influencing control.
- The filing is an amendment to Schedule 13G, indicating passive investment intent.
Financial Impact
No change in stake; BlackRock continues to hold 6.9% of Trevi Therapeutics.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0002012383-26-003855 |
| Document: Item_7.txt | 0002012383-26-003855 |
| Document: 0002012383-26-003855-index-headers.html | 0002012383-26-003855 |
| Document: 0002012383-26-003855-index.html | 0002012383-26-003855 |
| Document: 0002012383-26-003855.txt | 0002012383-26-003855 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 4d ago | SC 13G/A | $13.52 | awaiting T+20 | awaiting T+20 | $13.56 (+0.30%) |
Jun 11, 2026 20w ago | Institutional Cluster | $13.46 $18.40 | ▲ +36.70% | ▲ +34.81% | $13.56 (+0.74%) |
Jun 11, 2026 20w ago | Institutional Cluster | $13.46 $18.40 | ▲ +36.70% | ▲ +34.81% | $13.56 (+0.74%) |
Apr 21, 2026 27w ago | DEFA14A | $14.80 $13.24 | ▼ −10.54% | ▼ −13.71% | $13.56 (−8.38%) |
Apr 20, 2026 27w ago | Press Release | $14.62 $13.43 | ▼ −8.14% | ▼ −13.05% | $13.56 (−7.25%) |
Apr 17, 2026 28w ago | 424B5 | $15.40 $13.43 | ▲ +12.79% | ▲ +16.99% | $13.56 (+11.95%) |
Apr 17, 2026 28w ago | 8-K | $15.23 $15.08 | ▲ +0.98% | ▲ +6.36% | $13.56 (+10.97%) |
Apr 16, 2026 28w ago | Press Release | $15.23 $15.08 | ▼ −0.98% | ▼ −6.36% | $13.56 (−10.97%) |
Mar 17, 2026 32w ago | Press Release | $10.69 $14.54 | ▲ +36.02% | ▲ +29.97% | $13.56 (+26.85%) |
Mar 10, 2026 33w ago | Press Release | $11.94 $13.30 | ▲ +11.39% | ▲ +10.87% | $13.56 (+13.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers